Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bernard, Reimund"'
Autor:
Scott D. Solomon, Claudio Gimpelewicz, Yanntong Chiang, Lars Køber, M. Atif Ali, Bernard Reimund, Kenneth Dickstein, Georgia Tarnesby, William T. Abraham, Barry M. Massie, Henry Krum, John J.V. McMurray, Akshay S. Desai
Publikováno v:
European Journal of Heart Failure. 17:1075-1083
Aims and methods: To: (i) describe the baseline characteristics of patients in ATMOSPHERE and the changes in the planned analysis of ATMOSPHERE resulting from the mandated discontinuation of study treatment in patients with diabetes; (ii) compare the
Autor:
Michael Böhm, Bernard Reimund, Gregg C. Fonarow, Stephen J. Greene, Anastasia Lesogor, Margaret F. Prescott, Coordinators, Faiez Zannad, Tsushung A. Hua, Aldo P. Maggioni, Mihai Gheorghiade, Albert Kandra, Scott D. Solomon, Astronaut Investigators
Publikováno v:
European Journal of Heart Failure. 17:98-108
Aims The purpose of this study was to determine the prognostic significance and associated clinical profile of early post-discharge N-terminal pro-B-type natriuretic peptide (NT-proBNP) trajectory among patients hospitalized for worsening chronic hea
Autor:
Beata Sokolova, Alan Charney, Michele Senni, Jan Nociar, Hugh F. McIntyre, Fabian Chen, Bernard Reimund, Harinder Gogia, John J.V. McMurray, Manuel Martínez-Sellés, Rolf Wachter, Franco Cosmi, Peter Andreka, Antonio Reyes, Valeri Gelev, Ivan Majercak, Nina Shehova-Yankova, Mehmet Yilmaz, Zsolt Zilahi, Maurizio Volterrani, Arnab Sarkar, Enrique Galve, Steffen Fischer, Inder S. Anand, Maria Radomska, Juanjo J. Gómez-Doblas
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
European Journal of Heart Failure
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Consejería de Sanidad de la Comunidad de Madrid
European Journal of Heart Failure
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
WOS: 000383604800016
PubMed ID: 27170530
AimsTo assess the tolerability of initiating/uptitrating sacubitril/valsartan (LCZ696) from 50 to 200 mg twice daily (target dose) over 3 and 6 weeks in heart failure (HF) patients (ejection fraction
PubMed ID: 27170530
AimsTo assess the tolerability of initiating/uptitrating sacubitril/valsartan (LCZ696) from 50 to 200 mg twice daily (target dose) over 3 and 6 weeks in heart failure (HF) patients (ejection fraction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1001e5d98e27a0a25404494b5ffe463
https://hdl.handle.net/20.500.12530/26550
https://hdl.handle.net/20.500.12530/26550
Autor:
Stephanie Le Breton, Peter Baumgart, Andrzej Tykarski, Bernard Reimund, Philippe Ferber, Jaakko Tuomilehto
Publikováno v:
Blood Pressure. 17:15-23
To investigate the efficacy and tolerability of valsartan (Val) 320 mg once daily (o.d.), Val/hydrochlorothiazide (HCTZ) 320/12.5 mg o.d. and Val/HCTZ 320/25 mg o.d. in patients with hypertension not adequately controlled by Val monotherapy.This doub
Autor:
Henry, Krum, John J V, McMurray, William T, Abraham, Kenneth, Dickstein, Lars, Køber, Akshay S, Desai, Scott D, Solomon, Yanntong, Chiang, Claudio, Gimpelewicz, Bernard, Reimund, M Atif, Ali, Georgia, Tarnesby, Barry M, Massie
Publikováno v:
European journal of heart failure. 17(10)
To: (i) describe the baseline characteristics of patients in ATMOSPHERE and the changes in the planned analysis of ATMOSPHERE resulting from the mandated discontinuation of study treatment in patients with diabetes; (ii) compare the baseline characte
Autor:
Stephen J, Greene, Aldo P, Maggioni, Gregg C, Fonarow, Scott D, Solomon, Michael, Böhm, Albert, Kandra, Margaret F, Prescott, Bernard, Reimund, Tsushung A, Hua, Anastasia, Lesogor, Faiez, Zannad, Mihai, Gheorghiade
Publikováno v:
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2015, 17 (1), pp.98-108. ⟨10.1002/ejhf.201⟩
European Journal of Heart Failure, Oxford University Press (OUP), 2015, 17 (1), pp.98-108. ⟨10.1002/ejhf.201⟩
International audience; AIMS:The purpose of this study was to determine the prognostic significance and associated clinical profile of early post-discharge N-terminal pro-B-type natriuretic peptide (NT-proBNP) trajectory among patients hospitalized f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7afead8664ea425146e7ffc0db738f8c
https://hal.archives-ouvertes.fr/hal-01743490
https://hal.archives-ouvertes.fr/hal-01743490
Autor:
Claudio Gimpelewicz, Ashkay Desai, William T. Abraham, Albert Kandra, Kenneth Dickstein, Lars Køber, Bernard Reimund, Barry M. Massie, Juergen Armbrecht, John J.V. McMurray, Henning Rattunde, Henry Krum
Publikováno v:
European journal of heart failure. 13(1)
Aims The renin–angiotensin–aldosterone system (RAAS) represents a key therapeutic target in heart failure (HF) management. However, conventional agents that block this system induce a reflex increase in plasma renin activity (PRA), which may lead